Ultragenyx Pharmaceutical Inc. (RARE): Price and Financial Metrics
Ultragenyx Pharmaceutical Inc. (RARE)
Today's Latest Price: $61.13 USD
1.77 (-2.81%)
Updated Feb 14 12:00am
Add RARE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
RARE Stock Summary
- RARE's price/sales ratio is 41.76; that's higher than the P/S ratio of 96.37% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.17 for Ultragenyx Pharmaceutical Inc; that's greater than it is for just 10.4% of US stocks.
- Revenue growth over the past 12 months for Ultragenyx Pharmaceutical Inc comes in at 124.13%, a number that bests 95.32% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Ultragenyx Pharmaceutical Inc, a group of peers worth examining would be BLUE, ARVN, DRNA, TBPH, and TBIO.
- RARE's SEC filings can be seen here. And to visit Ultragenyx Pharmaceutical Inc's official web site, go to www.ultragenyx.com.
RARE Daily Price Range
RARE 52-Week Price Range
RARE Stock Price Chart More Charts
RARE Price/Volume Stats
| Current price | $61.13 | 52-week high | $74.50 |
| Prev. close | $62.90 | 52-week low | $35.41 |
| Day low | $60.40 | Volume | 510,900 |
| Day high | $64.24 | Avg. volume | 584,394 |
| 50-day MA | $50.93 | Dividend yield | N/A |
| 200-day MA | $51.61 | Market Cap | 3.53B |
Ultragenyx Pharmaceutical Inc. (RARE) Company Bio
Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company was founded in 2010 and is based in Novato, California.
Loading social stream, please wait...